토모큐브

475960KOSDAQ

48.5 / 100

Reference Date: 2026-10-23

Financial Score18.0 / 40

News Sentiment12.5 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Rose 10.7% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

Tomocube develops advanced cell imaging equipment, such as HT-2H and HT-X1, based on Holotomography (HT) technology, revolutionizing biomedical research and diagnostics. Widely adopted by over 200 institutions across 50+ countries, including MIT and ETH Zurich, the company is expanding into industrial applications, enhancing growth potential through semiconductor and display measurement devices.

Number of Employees

76people

Average Salary

55.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

10.58Industry Average 1.200.0Point

8.8x industry avg (risky)

ROE

-11.91Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

3.03Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2024~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲90.4% (1-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲36.6% (1-year basis)

ROE Trend

0.0 / 4

Avg ROE -19.9% (improving, 2yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position1.0Point

Near 52w low (9%, downtrend)

Current 30,450Won52-week high 66,30052-week low 26,600

1-month return5.0Point

1m +10.73% (rising)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

0 totalPositive 0Neutral 0Negative 0